Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective for glycaemic control and weight loss in patients with type 2 diabetes (T2D). In this retrospective, observational study, we analysed glycated haemoglobin (HbA1c) and weight following switching to semaglutide fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingvay, Ildiko, Kirk, Andreas R., Lophaven, Søren, Wolden, Michael L., Shubrook, Jay H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947062/
https://www.ncbi.nlm.nih.gov/pubmed/33594582
http://dx.doi.org/10.1007/s13300-021-01010-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947062/
https://www.ncbi.nlm.nih.gov/pubmed/33594582
http://dx.doi.org/10.1007/s13300-021-01010-4

Ejemplares similares